Financhill
Buy
71

WAB Quote, Financials, Valuation and Earnings

Last price:
$192.99
Seasonality move :
4.2%
Day range:
$188.62 - $194.23
52-week range:
$123.76 - $207.51
Dividend yield:
0.41%
P/E ratio:
32.17x
P/S ratio:
3.30x
P/B ratio:
3.24x
Volume:
4.1M
Avg. volume:
1.2M
1-year change:
54.54%
Market cap:
$33.2B
Revenue:
$9.7B
EPS (TTM):
$6.00
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $8.2B $7.6B $7.8B $8.4B $9.7B
Revenue Growth (YoY) 87.92% -7.85% 3.52% 6.9% 15.73%
 
Cost of Revenues $5.9B $5.4B $5.5B $5.8B $6.7B
Gross Profit $2.3B $2.1B $2.4B $2.5B $2.9B
Gross Profit Margin 27.78% 28.28% 30.29% 30.38% 30.42%
 
R&D Expenses $210M $162M $176M $209M $218M
Selling, General & Admin $1.2B $948M $1B $1B $1.1B
Other Inc / (Exp) $3M $11M $38M $29M $44M
Operating Expenses $1.6B $1.4B $1.5B $1.5B $1.7B
Operating Income $663M $745M $876M $1B $1.3B
 
Net Interest Expenses $219M $199M $177M $186M $218M
EBT. Incl. Unusual Items $447M $557M $737M $854M $1.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $120M $145M $172M $213M $267M
Net Income to Company $327M $412M $565M $641M $825M
 
Minority Interest in Earnings -- $2M -$7M -$8M -$10M
Net Income to Common Excl Extra Items $327M $414M $558M $633M $815M
 
Basic EPS (Cont. Ops) $1.91 $2.18 $2.96 $3.46 $4.54
Diluted EPS (Cont. Ops) $1.84 $2.17 $2.96 $3.46 $4.53
Weighted Average Basic Share $170.5M $189.9M $187.7M $182.2M $178.8M
Weighted Average Diluted Share $177.3M $190.4M $188.1M $182.8M $179.5M
 
EBITDA $985M $1.1B $1.4B $1.5B $1.8B
EBIT $666M $756M $914M $1B $1.3B
 
Revenue (Reported) $8.2B $7.6B $7.8B $8.4B $9.7B
Operating Income (Reported) $663M $745M $876M $1B $1.3B
Operating Income (Adjusted) $666M $756M $914M $1B $1.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $1.9B $1.9B $2.1B $2.6B $2.7B
Revenue Growth (YoY) -6.82% 2.25% 9.12% 22.54% 4.43%
 
Cost of Revenues $1.3B $1.3B $1.4B $1.8B $1.8B
Gross Profit $566.2M $603M $648M $792M $880M
Gross Profit Margin 30.36% 31.62% 31.14% 31.06% 33.05%
 
R&D Expenses $36.5M $44M $54M $53M $50M
Selling, General & Admin $252.7M $269M $260M $295M $318M
Other Inc / (Exp) $14.3M -- $4M $10M -$3M
Operating Expenses $359.5M $386M $387M $422M $447M
Operating Income $206.7M $217M $261M $370M $433M
 
Net Interest Expenses $45.6M $42M $48M $60M $52M
EBT. Incl. Unusual Items $175.4M $175M $217M $320M $378M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $46.9M $43M $54M $78M $92M
Net Income to Company $128.5M $132M $163M $242M $286M
 
Minority Interest in Earnings -$400K -$1M -$3M -$2M -$3M
Net Income to Common Excl Extra Items $128.1M $131M $160M $240M $283M
 
Basic EPS (Cont. Ops) $0.67 $0.69 $0.88 $1.34 $1.63
Diluted EPS (Cont. Ops) $0.67 $0.69 $0.88 $1.33 $1.63
Weighted Average Basic Share $189.8M $187.6M $181.3M $178.6M $173.4M
Weighted Average Diluted Share $190.2M $188M $181.9M $179.2M $174.1M
 
EBITDA $328.1M $323M $370M $492M $553M
EBIT $221M $217M $265M $380M $430M
 
Revenue (Reported) $1.9B $1.9B $2.1B $2.6B $2.7B
Operating Income (Reported) $206.7M $217M $261M $370M $433M
Operating Income (Adjusted) $221M $217M $265M $380M $430M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $7.9B $7.8B $8.1B $9.5B $10.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.6B $5.6B $5.6B $6.6B $7B
Gross Profit $2.3B $2.2B $2.5B $2.8B $3.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $183.4M $162.3M $201M $217M $216M
Selling, General & Admin $1B $1B $1B $1.1B $1.2B
Other Inc / (Exp) $12.9M $30.2M $28M $30M $24M
Operating Expenses $1.5B $1.4B $1.5B $1.6B $1.7B
Operating Income $809.4M $773.6M $1B $1.2B $1.6B
 
Net Interest Expenses $208.5M $183.7M $177M $214M $203M
EBT. Incl. Unusual Items $613.8M $620.1M $879M $1B $1.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $150.8M $161.6M $204M $255M $335M
Net Income to Company $463M $458.5M $675M $767M $1.1B
 
Minority Interest in Earnings -$500K -$3M -$10M -$9M -$12M
Net Income to Common Excl Extra Items $462.5M $455.5M $665M $758M $1.1B
 
Basic EPS (Cont. Ops) $2.42 $2.40 $3.61 $4.20 $6.01
Diluted EPS (Cont. Ops) $2.42 $2.40 $3.61 $4.18 $6.00
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $1.2B $1.2B $1.5B $1.7B $2.1B
EBIT $822.3M $803.8M $1.1B $1.2B $1.6B
 
Revenue (Reported) $7.9B $7.8B $8.1B $9.5B $10.3B
Operating Income (Reported) $809.4M $773.6M $1B $1.2B $1.6B
Operating Income (Adjusted) $822.3M $803.8M $1.1B $1.2B $1.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $5.5B $5.7B $6.1B $7.2B $7.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $3.9B $4B $4.2B $5B $5.2B
Gross Profit $1.6B $1.7B $1.9B $2.2B $2.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $123.7M $124M $149M $157M $155M
Selling, General & Admin $712.9M $766M $757M $842M $913M
Other Inc / (Exp) $5.8M $25M $15M $16M -$3M
Operating Expenses $1B $1.1B $1.1B $1.2B $1.3B
Operating Income $583.4M $612M $764M $959M $1.3B
 
Net Interest Expenses $150.3M $135M $135M $163M $148M
EBT. Incl. Unusual Items $438.9M $502M $644M $812M $1.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $113.4M $130M $162M $204M $272M
Net Income to Company $325.5M $372M $482M $608M $854M
 
Minority Interest in Earnings $1M -$4M -$7M -$8M -$10M
Net Income to Common Excl Extra Items $326.5M $368M $475M $600M $844M
 
Basic EPS (Cont. Ops) $1.71 $1.94 $2.59 $3.34 $4.81
Diluted EPS (Cont. Ops) $1.71 $1.94 $2.59 $3.32 $4.80
Weighted Average Basic Share $570.4M $564.7M $547.7M $537.4M $525.3M
Weighted Average Diluted Share $571.8M $565.8M $549.3M $539.2M $527.3M
 
EBITDA $874.6M $969M $1.1B $1.3B $1.6B
EBIT $589.2M $637M $779M $975M $1.3B
 
Revenue (Reported) $5.5B $5.7B $6.1B $7.2B $7.8B
Operating Income (Reported) $583.4M $612M $764M $959M $1.3B
Operating Income (Adjusted) $589.2M $637M $779M $975M $1.3B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $604.2M $599M $473M $541M $620M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.1B $969M $1.1B $975M $1.2B
Inventory $1.8B $1.6B $1.7B $2B $2.3B
Prepaid Expenses -- -- -- -- --
Other Current Assets $150.9M $227M $193M $233M $267M
Total Current Assets $4.2B $3.9B $3.8B $4.3B $4.9B
 
Property Plant And Equipment $1.7B $1.6B $1.5B $1.4B $1.5B
Long-Term Investments -- -- -- -- --
Goodwill $8.4B $8.5B $8.6B $8.5B $8.8B
Other Intangibles $4.1B $3.9B $3.7B $3.4B $3.2B
Other Long-Term Assets $631.7M $619M $833M $850M $663M
Total Assets $18.9B $18.5B $18.5B $18.5B $19B
 
Accounts Payable $1.2B $909M $1B $1.3B $1.3B
Accrued Expenses $1.1B $985M $932M $843M $880M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $3.3B $3.2B $2.9B $3.5B $4.1B
 
Long-Term Debt $4.3B $3.8B $4.1B $3.8B $3.3B
Capital Leases -- -- -- -- --
Total Liabilities $9B $8.3B $8.2B $8.4B $8.5B
 
Common Stock $2M $2M $2M $2M $2M
Other Common Equity Adj -$382.6M -$339M -$466M -$661M -$590M
Common Equity $10B $10.1B $10.2B $10.1B $10.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $37.1M $30M $38M $45M $37M
Total Equity $10B $10.2B $10.2B $10.1B $10.5B
 
Total Liabilities and Equity $18.9B $18.5B $18.5B $18.5B $19B
Cash and Short Terms $604.2M $599M $473M $541M $620M
Total Debt $4.4B $4.2B $4.1B $4B $4.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $559.3M $456.4M $514M $385M $401M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1B $960.3M $1B $1.1B $1.2B
Inventory $1.8B $1.7B $2B $2.2B $2.4B
Prepaid Expenses -- -- -- -- --
Other Current Assets $163.7M $247.1M $200M $282M $202M
Total Current Assets $3.9B $3.8B $4.2B $4.6B $4.8B
 
Property Plant And Equipment $1.6B $1.5B $1.4B $1.4B $1.4B
Long-Term Investments -- -- -- -- --
Goodwill $8.4B $8.6B $8.4B $8.6B $8.8B
Other Intangibles $3.9B $3.8B $3.4B $3.3B $3B
Other Long-Term Assets $648.8M $698.3M $890M $890M $649M
Total Assets $18.4B $18.4B $18.3B $18.8B $18.6B
 
Accounts Payable $962M $947.3M $1.2B $1.2B $1.3B
Accrued Expenses $927M $994.3M $902M $902M $896M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $3.2B $2.8B $3.3B $3.9B $3.7B
 
Long-Term Debt $3.8B $4.1B $3.8B $3.3B $3.5B
Capital Leases -- -- -- -- --
Total Liabilities $8.4B $8.2B $8.3B $8.4B $8.4B
 
Common Stock $2M $2M $2M $2M $2M
Other Common Equity Adj -$482.2M -$432.6M -$808M -$713M -$607M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $35.5M $34.6M $44M $41M $41M
Total Equity $10.1B $10.2B $9.9B $10.4B $10.3B
 
Total Liabilities and Equity $18.4B $18.4B $18.3B $18.8B $18.6B
Cash and Short Terms $559.3M $456.4M $514M $385M $401M
Total Debt $4.3B $4.1B $4.1B $4B $4B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $327M $412M $565M $641M $825M
Depreciation & Amoritzation $319M $385M $441M $426M $477M
Stock-Based Compensation $50M $20M $46M $41M $47M
Change in Accounts Receivable -$6M $315M -$76M -$52M -$195M
Change in Inventories $256M $181M -$41M -$368M -$58M
Cash From Operations $1B $784M $1.1B $1B $1.2B
 
Capital Expenditures $186M $136M $130M $149M $186M
Cash Acquisitions -$3B -$40M -$435M -$89M -$308M
Cash From Investing -$3.2B -$155M -$540M -$235M -$492M
 
Dividends Paid (Ex Special Dividend) -$82M -$93M -$92M -$111M -$123M
Special Dividend Paid
Long-Term Debt Issued $4B $3.9B $5.4B $6.1B $5.6B
Long-Term Debt Repaid -$3.4B -$4.1B -$5.6B -$6.1B -$5.5B
Repurchase of Common Stock -- -$207M -$300M -$473M -$409M
Other Financing Activities -$15M -$120M -$100M -$94M -$143M
Cash From Financing $461M -$619M -$653M -$708M -$633M
 
Beginning Cash (CF) $2.3B $604M $599M $473M $541M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.7B $10M -$120M $95M $76M
Ending Cash (CF) $604M $599M $473M $541M $620M
 
Levered Free Cash Flow $830M $648M $943M $889M $1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $128.5M $132M $163M $242M $286M
Depreciation & Amoritzation $107.1M $106M $105M $112M $123M
Stock-Based Compensation $11.9M $10M $10M $14M $18M
Change in Accounts Receivable -$900K $64M -$84M -$64M $54M
Change in Inventories $38.1M -$40M -$145M $47M $5M
Cash From Operations $229.5M $244M $204M $425M $542M
 
Capital Expenditures $31.1M $23M $32M $39M $46M
Cash Acquisitions -- -- -- -$4M $4M
Cash From Investing -$21.7M -$23M -$32M -$43M -$49M
 
Dividends Paid (Ex Special Dividend) -$22.8M -$23M -$28M -$30M -$35M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $843M $1.3B $1.2B $1.4B $69M
Long-Term Debt Repaid -$1.1B -$1.3B -$1.3B -$1.7B -$73M
Repurchase of Common Stock -- -$199M -$1M -- -$599M
Other Financing Activities $300K $2M -$3M $2M -$48M
Cash From Financing -$237.3M -$220M -$139M -$353M -$686M
 
Beginning Cash (CF) $587.9M $454M $501M $371M $595M
Foreign Exchange Rate Adjustment $900K $1M -$20M -$8M $8M
Additions / Reductions -$29.5M $1M $33M $29M -$193M
Ending Cash (CF) $559.3M $456M $514M $392M $410M
 
Levered Free Cash Flow $198.4M $221M $172M $386M $496M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $463M $458.5M $675M $767M $1.1B
Depreciation & Amoritzation $345M $431.6M $429M $438M $486M
Stock-Based Compensation $31.5M $36.4M $42M $47M $55M
Change in Accounts Receivable $271.5M $104.8M -$150M -$227M -$73M
Change in Inventories $205.1M $141.2M -$410M -$168M $28M
Cash From Operations $906.4M $1.1B $942M $925M $1.8B
 
Capital Expenditures $172.1M $115.3M $134M $176M $200M
Cash Acquisitions -$35.7M -$404.7M -$99M -$247M -$77M
Cash From Investing -$188.1M -$510.1M -$214M -$422M -$262M
 
Dividends Paid (Ex Special Dividend) -$93M -$92.8M -$106M -$120M -$137M
Special Dividend Paid
Long-Term Debt Issued $4B $5.3B $5.6B $5.9B $3.1B
Long-Term Debt Repaid -$4.5B -$5.5B -$5.5B -$5.9B -$3.2B
Repurchase of Common Stock -$105.3M -$301.7M -$500M -$325M -$1.1B
Other Financing Activities -$4.6M -$116.8M -$103M -$117M -$182M
Cash From Financing -$716.9M -$691.2M -$615M -$636M -$1.5B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.4M -$116.4M $113M -$133M $16M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $734.3M $969.6M $808M $749M $1.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $325.5M $372M $482M $608M $854M
Depreciation & Amoritzation $285.4M $332M $320M $332M $341M
Stock-Based Compensation $17.6M $34M $30M $36M $44M
Change in Accounts Receivable $245.2M $35M -$39M -$214M -$92M
Change in Inventories $7.8M -$32M -$401M -$201M -$115M
Cash From Operations $458.1M $759M $628M $515M $1.1B
 
Capital Expenditures $98.7M $78M $82M $109M $123M
Cash Acquisitions -$40.3M -$405M -$69M -$227M $4M
Cash From Investing -$119.9M -$475M -$149M -$336M -$106M
 
Dividends Paid (Ex Special Dividend) -$69.2M -$69M -$83M -$92M -$106M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.9B $4.3B $4.6B $4.4B $1.9B
Long-Term Debt Repaid -$3.1B -$4.5B -$4.5B -$4.3B -$1.9B
Repurchase of Common Stock -$105.3M -$200M -$400M -$252M -$974M
Other Financing Activities -$5.2M -$2M -$5M -$28M -$67M
Cash From Financing -$360.8M -$433M -$395M -$323M -$1.2B
 
Beginning Cash (CF) $1.8B $1.5B $1.5B $1.3B $1.9B
Foreign Exchange Rate Adjustment -$22.3M $6M -$43M -$5M -$6M
Additions / Reductions -$22.6M -$149M $84M -$144M -$204M
Ending Cash (CF) $1.8B $1.4B $1.5B $1.2B $1.6B
 
Levered Free Cash Flow $359.4M $681M $546M $406M $988M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock